Cancer Gene Therapy
p53 Trials Expanded to Europe and Japan
Published in Gene Therapy Weekly, February 24th, 1997
"We are very pleased with the results, to date, of our collaboration with Introgen," said Thierry Soursac, M.D., Ph.D., RPR Gencell. "In 1997, RPR Gencell is planning to begin two Phase I trials in Europe for both head and neck cancer and hepatocellular cancer and, pending our review of the results of Introgen's ongoing Phase I trials, we plan to conduct a Phase II trial in North America for the treatment of head and neck cancer and possibly other tumor types."
An Investigational New Drug application...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1997-02-24)
More Articles from Gene Therapy Weekly
- Gene Delivery
Improved Cationic Lipid Formulations Increase Efficiency, Physical Stability - Cardiovascular
Adv-Mediated Transfer of hsp70i Protects Against Ischemia - AIDS Therapies (Clinical Trials)
GEM 91 Moves Into Confirmatory Trial in Advanced HIV Patients - Cancer Gene Therapy (Chemokines)
MIP-1(alpha) Gene Transfer Reduced Tumorigenicity and Induced Protective Immunity - Drug Development
Isis Pharmaceuticals Touts New Drug Therapies - Genetics
Gene for Maleness Discovery Wins Amory Prize - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
